GlassScriptPhysician profile
Jeremy D Good
NPI 1104196294
$4,399.51
in general payments reported to CMS, 2019-2025
27 companies · $1,335 in 2025
The $1,335 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $224 · 2022: $760 · 2023: $989 · 2024: $1,091 · 2025: $1,335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,257 · Education: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,256.68 |
| Education | $158.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,139.06 | 2022-2025 | Erleada |
| Astellas Pharma US INC | $674.49 | 2021-2024 | Myrbetriq, Xtandi |
| Sumitomo Pharma America, INC. | $478.05 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $448.45 | 2023-2025 | |
| Olympus America INC. | $294.44 | 2021-2025 | Itind System |
| Abbvie INC. | $176.30 | 2023-2025 | |
| Endo Pharmaceuticals INC. | $165.78 | 2021-2023 | Aveed, Xiaflex, Edex |
| Ferring Pharmaceuticals INC. | $160.58 | 2024-2025 | Adstiladrin |
| Coloplast Corp | $135.38 | 2023-2025 | Speedicath, Luja Coude |
| Endo USA, INC. | $125.50 | 2024-2025 | Xiaflex, Aveed, Edex |
| Merck Sharp & Dohme LLC | $84.44 | 2021-2023 | Keytruda, Lynparza |
| Bayer Healthcare Pharmaceuticals INC. | $66.34 | 2021-2025 | |
| Urovant Sciences INC | $63.81 | 2021-2022 | |
| 180 Medical, INC. | $55.40 | 2022 | |
| Teleflex LLC | $55.12 | 2022-2023 | Urolift |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $39.04 | 2024 | |
| Procept Biorobotics Corporation | $29.41 | 2024 | Aquabeam System |
| Progenics Pharmaceuticals, INC. | $27.70 | 2025 | |
| Hollister Incorporated | $27.40 | 2023 | Vapro Plus Pocket |
| Convatec INC. | $26.02 | 2021 | |
| Novartis Pharmaceuticals Corporation | $25.24 | 2025 | |
| Lilly USA, LLC | $20.70 | 2025 | Zepbound, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $19.65 | 2022 | |
| Accord Healthcare, INC. | $17.38 | 2025 | |
| Blue Earth Diagnostics | $16.48 | 2022 | |
| Axonics, INC. | $14.46 | 2024 | Axonics |
| Abc Home Medical Supply, INC. | $12.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremy Good listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.